AU2021261374A1 - Compositions and methods using snRNA components - Google Patents

Info

Publication number

AU2021261374A1

AU2021261374A1 AU2021261374A AU2021261374A AU2021261374A1 AU 2021261374 A1 AU2021261374 A1 AU 2021261374A1 AU 2021261374 A AU2021261374 A AU 2021261374A AU 2021261374 A AU2021261374 A AU 2021261374A AU 2021261374 A1 AU2021261374 A1 AU 2021261374A1

Authority

AU

Australia

Prior art keywords

bases

engineered polynucleotide

nucleotides

rna

engineered

Prior art date

2020-04-22

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 53
• 102000039471 Small Nuclear RNA Human genes 0.000 title claims description 17
• 239000000203 mixture Substances 0.000 title abstract description 37
• 108020004688 Small Nuclear RNA Proteins 0.000 title 1
• 102000040430 polynucleotide Human genes 0.000 claims abstract description 725
• 108091033319 polynucleotide Proteins 0.000 claims abstract description 724
• 239000002157 polynucleotide Substances 0.000 claims abstract description 719
• 125000003729 nucleotide group Chemical group 0.000 claims abstract description 569
• 239000002773 nucleotide Substances 0.000 claims abstract description 560
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 71
• 201000010099 disease Diseases 0.000 claims abstract description 62
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 9
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 422
• 108091029842 small nuclear ribonucleic acid Proteins 0.000 claims description 180
• 230000008685 targeting Effects 0.000 claims description 165
• 230000035772 mutation Effects 0.000 claims description 103
• 238000010357 RNA editing Methods 0.000 claims description 100
• 230000026279 RNA modification Effects 0.000 claims description 100
• 239000013598 vector Substances 0.000 claims description 87
• 108090000623 proteins and genes Proteins 0.000 claims description 86
• 102000004169 proteins and genes Human genes 0.000 claims description 55
• 230000027455 binding Effects 0.000 claims description 42
• 102100026882 Alpha-synuclein Human genes 0.000 claims description 39
• 102100032693 Leucine-rich repeat serine/threonine-protein kinase 2 Human genes 0.000 claims description 39
• 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 claims description 33
• 230000000295 complement effect Effects 0.000 claims description 33
• 108091026823 U7 small nuclear RNA Proteins 0.000 claims description 26
• 101000823116 Homo sapiens Alpha-1-antitrypsin Proteins 0.000 claims description 25
• 102100022712 Alpha-1-antitrypsin Human genes 0.000 claims description 24
• 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 claims description 22
• 239000013607 AAV vector Substances 0.000 claims description 20
• 101000865408 Homo sapiens Double-stranded RNA-specific adenosine deaminase Proteins 0.000 claims description 19
• 102100029791 Double-stranded RNA-specific adenosine deaminase Human genes 0.000 claims description 17
• 208000018737 Parkinson disease Diseases 0.000 claims description 16
• 239000013603 viral vector Substances 0.000 claims description 16
• 101000584785 Homo sapiens Ras-related protein Rab-7a Proteins 0.000 claims description 15
• 101000801643 Homo sapiens Retinal-specific phospholipid-transporting ATPase ABCA4 Proteins 0.000 claims description 15
• 102100030019 Ras-related protein Rab-7a Human genes 0.000 claims description 15
• 102100033617 Retinal-specific phospholipid-transporting ATPase ABCA4 Human genes 0.000 claims description 15
• 239000012634 fragment Substances 0.000 claims description 14
• 102100038191 Double-stranded RNA-specific editase 1 Human genes 0.000 claims description 13
• 101000742223 Homo sapiens Double-stranded RNA-specific editase 1 Proteins 0.000 claims description 13
• 208000024827 Alzheimer disease Diseases 0.000 claims description 12
• 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 claims description 11
• 102100027591 Copper-transporting ATPase 2 Human genes 0.000 claims description 11
• 101000936280 Homo sapiens Copper-transporting ATPase 2 Proteins 0.000 claims description 11
• 229910052772 Samarium Inorganic materials 0.000 claims description 11
• 102000013498 tau Proteins Human genes 0.000 claims description 9
• 108010026424 tau Proteins Proteins 0.000 claims description 9
• 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 8
• 241001634120 Adeno-associated virus - 5 Species 0.000 claims description 8
• 208000027073 Stargardt disease Diseases 0.000 claims description 8
• 208000006682 alpha 1-Antitrypsin Deficiency Diseases 0.000 claims description 8
• 229940104302 cytosine Drugs 0.000 claims description 8
• 238000002347 injection Methods 0.000 claims description 8
• 239000007924 injection Substances 0.000 claims description 8
• 101001045440 Homo sapiens Beta-hexosaminidase subunit alpha Proteins 0.000 claims description 7
• 229960000643 adenine Drugs 0.000 claims description 7
• 201000006938 muscular dystrophy Diseases 0.000 claims description 7
• 239000002105 nanoparticle Substances 0.000 claims description 7
• 238000011144 upstream manufacturing Methods 0.000 claims description 7
• KQLXBKWUVBMXEM-UHFFFAOYSA-N 2-amino-3,7-dihydropurin-6-one;7h-purin-6-amine Chemical compound NC1=NC=NC2=C1NC=N2.O=C1NC(N)=NC2=C1NC=N2 KQLXBKWUVBMXEM-UHFFFAOYSA-N 0.000 claims description 6
• 102100037242 Amiloride-sensitive sodium channel subunit alpha Human genes 0.000 claims description 6
• 108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 claims description 6
• 101000740448 Homo sapiens Amiloride-sensitive sodium channel subunit alpha Proteins 0.000 claims description 6
• 101001098868 Homo sapiens Proprotein convertase subtilisin/kexin type 9 Proteins 0.000 claims description 6
• 108010020246 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Proteins 0.000 claims description 6
• 102100038955 Proprotein convertase subtilisin/kexin type 9 Human genes 0.000 claims description 6
• 208000006289 Rett Syndrome Diseases 0.000 claims description 6
• 102000008371 intracellularly ATP-gated chloride channel activity proteins Human genes 0.000 claims description 6
• 102220060482 rs786201985 Human genes 0.000 claims description 6
• 102100030755 5-aminolevulinate synthase, nonspecific, mitochondrial Human genes 0.000 claims description 5
• 241001164825 Adeno-associated virus - 8 Species 0.000 claims description 5
• 208000010693 Charcot-Marie-Tooth Disease Diseases 0.000 claims description 5
• 101000843649 Homo sapiens 5-aminolevulinate synthase, nonspecific, mitochondrial Proteins 0.000 claims description 5
• 208000022292 Tay-Sachs disease Diseases 0.000 claims description 5
• 102200071038 rs1800562 Human genes 0.000 claims description 5
• 102000009572 RNA Polymerase II Human genes 0.000 claims description 4
• 108010009460 RNA Polymerase II Proteins 0.000 claims description 4
• 108091026838 U1 spliceosomal RNA Proteins 0.000 claims description 4
• 108091023045 Untranslated Region Proteins 0.000 claims description 4
• 238000007913 intrathecal administration Methods 0.000 claims description 4
• 230000003612 virological effect Effects 0.000 claims description 4
• 208000023105 Huntington disease Diseases 0.000 claims description 3
• 108091026898 Leader sequence (mRNA) Proteins 0.000 claims description 3
• 108091036066 Three prime untranslated region Proteins 0.000 claims description 3
• 239000003085 diluting agent Substances 0.000 claims description 3
• 238000007914 intraventricular administration Methods 0.000 claims description 3
• 239000002502 liposome Substances 0.000 claims description 3
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
• 239000000412 dendrimer Substances 0.000 claims description 2
• 229920000736 dendritic polymer Polymers 0.000 claims description 2
• 238000010253 intravenous injection Methods 0.000 claims description 2
• 238000011200 topical administration Methods 0.000 claims description 2
• 230000014621 translational initiation Effects 0.000 claims description 2
• 238000001990 intravenous administration Methods 0.000 claims 4
• 238000007918 intramuscular administration Methods 0.000 claims 2
• 238000007912 intraperitoneal administration Methods 0.000 claims 2
• 238000007920 subcutaneous administration Methods 0.000 claims 2
• BFPVYAOMWYSCLY-YTZISMEFSA-N (2s)-1-[(2s)-2-[(2-aminoacetyl)amino]propanoyl]-n-[(2s)-1-[[(2s)-1-[[(2s)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)CN)C1=CC=CC=C1 BFPVYAOMWYSCLY-YTZISMEFSA-N 0.000 claims 1
• 102000048988 Hemochromatosis Human genes 0.000 claims 1
• 108700022944 Hemochromatosis Proteins 0.000 claims 1
• 101150065637 Hfe gene Proteins 0.000 claims 1
• 239000006071 cream Substances 0.000 claims 1
• 238000001631 haemodialysis Methods 0.000 claims 1
• 230000000322 hemodialysis Effects 0.000 claims 1
• 230000008595 infiltration Effects 0.000 claims 1
• 238000001764 infiltration Methods 0.000 claims 1
• 238000001802 infusion Methods 0.000 claims 1
• 238000001361 intraarterial administration Methods 0.000 claims 1
• 238000000185 intracerebroventricular administration Methods 0.000 claims 1
• 238000007919 intrasynovial administration Methods 0.000 claims 1
• 230000002262 irrigation Effects 0.000 claims 1
• 238000003973 irrigation Methods 0.000 claims 1
• 239000006210 lotion Substances 0.000 claims 1
• 239000002674 ointment Substances 0.000 claims 1
• 238000007911 parenteral administration Methods 0.000 claims 1
• 230000003239 periodontal effect Effects 0.000 claims 1
• 230000000699 topical effect Effects 0.000 claims 1
• 230000001296 transplacental effect Effects 0.000 claims 1
• 229920002477 rna polymer Polymers 0.000 description 411
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 405
• 239000000758 substrate Substances 0.000 description 340
• 108020005004 Guide RNA Proteins 0.000 description 142
• 108020004999 messenger RNA Proteins 0.000 description 82
• 125000006850 spacer group Chemical group 0.000 description 70
• 238000007385 chemical modification Methods 0.000 description 58
• 230000014509 gene expression Effects 0.000 description 41
• 230000004048 modification Effects 0.000 description 40
• 238000012986 modification Methods 0.000 description 40
• 239000002243 precursor Substances 0.000 description 36
• 101000941879 Homo sapiens Leucine-rich repeat serine/threonine-protein kinase 2 Proteins 0.000 description 33
• 210000004027 cell Anatomy 0.000 description 33
• 150000007523 nucleic acids Chemical class 0.000 description 28
• 108020004414 DNA Proteins 0.000 description 24
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 24
• 102000039446 nucleic acids Human genes 0.000 description 22
• 108020004707 nucleic acids Proteins 0.000 description 22
• 230000007115 recruitment Effects 0.000 description 21
• 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 20
• 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 20
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 20
• 108090000994 Catalytic RNA Proteins 0.000 description 20
• 102000053642 Catalytic RNA Human genes 0.000 description 20
• 108090000185 alpha-Synuclein Proteins 0.000 description 20
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 20
• 108091092562 ribozyme Proteins 0.000 description 20
• -1 ALASl Proteins 0.000 description 18
• 108700024394 Exon Proteins 0.000 description 18
• 238000009396 hybridization Methods 0.000 description 18
• 239000000523 sample Substances 0.000 description 18
• 230000000694 effects Effects 0.000 description 17
• 108090000765 processed proteins & peptides Proteins 0.000 description 16
• 241000124008 Mammalia Species 0.000 description 15
• 102000004196 processed proteins & peptides Human genes 0.000 description 15
• 108020005345 3' Untranslated Regions Proteins 0.000 description 14
• 108091092195 Intron Proteins 0.000 description 14
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 14
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 14
• 210000001519 tissue Anatomy 0.000 description 14
• 229910019142 PO4 Inorganic materials 0.000 description 13
• 238000003556 assay Methods 0.000 description 13
• 238000011304 droplet digital PCR Methods 0.000 description 13
• 239000010452 phosphate Substances 0.000 description 13
• 229920001184 polypeptide Polymers 0.000 description 13
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 13
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 12
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 12
• 102200092160 rs34637584 Human genes 0.000 description 12
• 238000003197 gene knockdown Methods 0.000 description 11
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
• 108091028043 Nucleic acid sequence Proteins 0.000 description 10
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 10
• 125000000217 alkyl group Chemical group 0.000 description 10
• 230000000692 anti-sense effect Effects 0.000 description 10
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 10
• 238000012217 deletion Methods 0.000 description 10
• 230000037430 deletion Effects 0.000 description 10
• 239000002158 endotoxin Substances 0.000 description 10
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 10
• 150000004713 phosphodiesters Chemical group 0.000 description 10
• 239000000047 product Substances 0.000 description 10
• 238000007480 sanger sequencing Methods 0.000 description 10
• 239000004055 small Interfering RNA Substances 0.000 description 10
• 230000001225 therapeutic effect Effects 0.000 description 10
• 241001465754 Metazoa Species 0.000 description 9
• 150000001413 amino acids Chemical class 0.000 description 9
• 125000003118 aryl group Chemical group 0.000 description 9
• 238000006243 chemical reaction Methods 0.000 description 9
• 208000035475 disorder Diseases 0.000 description 9
• 230000006870 function Effects 0.000 description 9
• 238000012545 processing Methods 0.000 description 9
• 102000004190 Enzymes Human genes 0.000 description 8
• 108090000790 Enzymes Proteins 0.000 description 8
• 210000004899 c-terminal region Anatomy 0.000 description 8
• 229940088598 enzyme Drugs 0.000 description 8
• 108020004705 Codon Proteins 0.000 description 7
• 208000011231 Crohn disease Diseases 0.000 description 7
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 7
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 7
• 108010033040 Histones Proteins 0.000 description 7
• 108091027974 Mature messenger RNA Proteins 0.000 description 7
• 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 7
• 238000003776 cleavage reaction Methods 0.000 description 7
• 101150015424 dmd gene Proteins 0.000 description 7
• 230000009368 gene silencing by RNA Effects 0.000 description 7
• 238000000338 in vitro Methods 0.000 description 7
• 229960003786 inosine Drugs 0.000 description 7
• 239000013612 plasmid Substances 0.000 description 7
• 238000012163 sequencing technique Methods 0.000 description 7
• 229940113082 thymine Drugs 0.000 description 7
• 108091026890 Coding region Proteins 0.000 description 6
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 6
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical class C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 6
• 108010014594 Heterogeneous Nuclear Ribonucleoprotein A1 Proteins 0.000 description 6
• 102000017013 Heterogeneous Nuclear Ribonucleoprotein A1 Human genes 0.000 description 6
• 101001053946 Homo sapiens Dystrophin Proteins 0.000 description 6
• 101100086350 Homo sapiens RAB7A gene Proteins 0.000 description 6
• 229930010555 Inosine Natural products 0.000 description 6
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 6
• 102100021244 Integral membrane protein GPR180 Human genes 0.000 description 6
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 6
• 108091027967 Small hairpin RNA Proteins 0.000 description 6
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 6
• 239000007864 aqueous solution Substances 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 229960002685 biotin Drugs 0.000 description 6
• 239000011616 biotin Substances 0.000 description 6
• 210000003169 central nervous system Anatomy 0.000 description 6
• 238000012937 correction Methods 0.000 description 6
• 102000057878 human DMD Human genes 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 230000007017 scission Effects 0.000 description 6
• 238000013518 transcription Methods 0.000 description 6
• 230000035897 transcription Effects 0.000 description 6
• 230000014616 translation Effects 0.000 description 6
• 229940035893 uracil Drugs 0.000 description 6
• 229930024421 Adenine Natural products 0.000 description 5
• 108700028369 Alleles Proteins 0.000 description 5
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 5
• 108091033409 CRISPR Proteins 0.000 description 5
• 108700011259 MicroRNAs Proteins 0.000 description 5
• 101710163270 Nuclease Proteins 0.000 description 5
• 108091000080 Phosphotransferase Proteins 0.000 description 5
• 108020005067 RNA Splice Sites Proteins 0.000 description 5
• 230000006819 RNA synthesis Effects 0.000 description 5
• 108020004459 Small interfering RNA Proteins 0.000 description 5
• 108020004566 Transfer RNA Proteins 0.000 description 5
• 229960005305 adenosine Drugs 0.000 description 5
• 125000003710 aryl alkyl group Chemical group 0.000 description 5
• 235000020958 biotin Nutrition 0.000 description 5
• 229910052799 carbon Inorganic materials 0.000 description 5
• 239000002679 microRNA Substances 0.000 description 5
• 230000004770 neurodegeneration Effects 0.000 description 5
• 208000015122 neurodegenerative disease Diseases 0.000 description 5
• 238000005192 partition Methods 0.000 description 5
• 230000001717 pathogenic effect Effects 0.000 description 5
• 102000020233 phosphotransferase Human genes 0.000 description 5
• 108020004418 ribosomal RNA Proteins 0.000 description 5
• 229910052717 sulfur Inorganic materials 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
• 102000053602 DNA Human genes 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 206010028980 Neoplasm Diseases 0.000 description 4
• 208000012902 Nervous system disease Diseases 0.000 description 4
• 208000025966 Neurological disease Diseases 0.000 description 4
• 108020004485 Nonsense Codon Proteins 0.000 description 4
• WSDRAZIPGVLSNP-UHFFFAOYSA-N O.P(=O)(O)(O)O.O.O.P(=O)(O)(O)O Chemical group O.P(=O)(O)(O)O.O.O.P(=O)(O)(O)O WSDRAZIPGVLSNP-UHFFFAOYSA-N 0.000 description 4
• 208000002193 Pain Diseases 0.000 description 4
• 101150030875 RAB7A gene Proteins 0.000 description 4
• 108091081024 Start codon Proteins 0.000 description 4
• 230000004075 alteration Effects 0.000 description 4
• 201000011510 cancer Diseases 0.000 description 4
• 230000015556 catabolic process Effects 0.000 description 4
• 230000001413 cellular effect Effects 0.000 description 4
• 230000008859 change Effects 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 238000006731 degradation reaction Methods 0.000 description 4
• 230000004069 differentiation Effects 0.000 description 4
• 230000004927 fusion Effects 0.000 description 4
• 229910052739 hydrogen Inorganic materials 0.000 description 4
• 238000000099 in vitro assay Methods 0.000 description 4
• 238000003780 insertion Methods 0.000 description 4
• 230000037431 insertion Effects 0.000 description 4
• 238000005304 joining Methods 0.000 description 4
• 210000002569 neuron Anatomy 0.000 description 4
• 230000002018 overexpression Effects 0.000 description 4
• 125000004437 phosphorous atom Chemical group 0.000 description 4
• ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 4
• 238000003753 real-time PCR Methods 0.000 description 4
• 101150033305 rtcB gene Proteins 0.000 description 4
• 241000894007 species Species 0.000 description 4
• 208000002320 spinal muscular atrophy Diseases 0.000 description 4
• 239000000126 substance Substances 0.000 description 4
• 238000006467 substitution reaction Methods 0.000 description 4
• 208000024891 symptom Diseases 0.000 description 4
• ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 3
• 241000972680 Adeno-associated virus - 6 Species 0.000 description 3
• 108091093088 Amplicon Proteins 0.000 description 3
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
• 108091035707 Consensus sequence Proteins 0.000 description 3
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 3
• 108010050904 Interferons Proteins 0.000 description 3
• 102000014150 Interferons Human genes 0.000 description 3
• 208000001294 Nociceptive Pain Diseases 0.000 description 3
• 238000012408 PCR amplification Methods 0.000 description 3
• 108010029485 Protein Isoforms Proteins 0.000 description 3
• 102000001708 Protein Isoforms Human genes 0.000 description 3
• 101150110423 SNCA gene Proteins 0.000 description 3
• 108010003165 Small Nuclear Ribonucleoproteins Proteins 0.000 description 3
• 102000004598 Small Nuclear Ribonucleoproteins Human genes 0.000 description 3
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
• 238000010459 TALEN Methods 0.000 description 3
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 3
• 108091026822 U6 spliceosomal RNA Proteins 0.000 description 3
• 210000005221 acidic domain Anatomy 0.000 description 3
• 150000003838 adenosines Chemical class 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 238000013459 approach Methods 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 125000004432 carbon atom Chemical group C* 0.000 description 3
• 230000003197 catalytic effect Effects 0.000 description 3
• 239000000470 constituent Substances 0.000 description 3
• 230000001276 controlling effect Effects 0.000 description 3
• 230000007423 decrease Effects 0.000 description 3
• 239000005547 deoxyribonucleotide Substances 0.000 description 3
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 230000018109 developmental process Effects 0.000 description 3
• 238000007847 digital PCR Methods 0.000 description 3
• 238000002474 experimental method Methods 0.000 description 3
• 210000001035 gastrointestinal tract Anatomy 0.000 description 3
• 125000000623 heterocyclic group Chemical group 0.000 description 3
• 239000001257 hydrogen Substances 0.000 description 3
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 229940079322 interferon Drugs 0.000 description 3
• 230000004576 lipid-binding Effects 0.000 description 3
• 210000004072 lung Anatomy 0.000 description 3
• 230000014759 maintenance of location Effects 0.000 description 3
• 238000004519 manufacturing process Methods 0.000 description 3
• 210000004498 neuroglial cell Anatomy 0.000 description 3
• 230000037434 nonsense mutation Effects 0.000 description 3
• 239000002777 nucleoside Substances 0.000 description 3
• 150000003833 nucleoside derivatives Chemical class 0.000 description 3
• 230000036961 partial effect Effects 0.000 description 3
• 230000007170 pathology Effects 0.000 description 3
• 230000002829 reductive effect Effects 0.000 description 3
• 210000003705 ribosome Anatomy 0.000 description 3
• 102200092222 rs33939927 Human genes 0.000 description 3
• 102200092167 rs35801418 Human genes 0.000 description 3
• 239000011593 sulfur Substances 0.000 description 3
• 238000001890 transfection Methods 0.000 description 3
• VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
• 108020003589 5' Untranslated Regions Proteins 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 101150039555 ABCA4 gene Proteins 0.000 description 2
• 108010079649 APOBEC-1 Deaminase Proteins 0.000 description 2
• 108010004483 APOBEC-3G Deaminase Proteins 0.000 description 2
• 108091023043 Alu Element Proteins 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 108091032955 Bacterial small RNA Proteins 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 102100040399 C->U-editing enzyme APOBEC-2 Human genes 0.000 description 2
• 238000010354 CRISPR gene editing Methods 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 241000700199 Cavia porcellus Species 0.000 description 2
• 241000282693 Cercopithecidae Species 0.000 description 2
• 108020004635 Complementary DNA Proteins 0.000 description 2
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
• 201000003883 Cystic fibrosis Diseases 0.000 description 2
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
• 102100040263 DNA dC->dU-editing enzyme APOBEC-3A Human genes 0.000 description 2
• 102100040262 DNA dC->dU-editing enzyme APOBEC-3B Human genes 0.000 description 2
• 102100040261 DNA dC->dU-editing enzyme APOBEC-3C Human genes 0.000 description 2
• 102100040264 DNA dC->dU-editing enzyme APOBEC-3D Human genes 0.000 description 2
• 102100040266 DNA dC->dU-editing enzyme APOBEC-3F Human genes 0.000 description 2
• 102100038076 DNA dC->dU-editing enzyme APOBEC-3G Human genes 0.000 description 2
• 102100038050 DNA dC->dU-editing enzyme APOBEC-3H Human genes 0.000 description 2
• 101710082737 DNA dC->dU-editing enzyme APOBEC-3H Proteins 0.000 description 2
• 241000702421 Dependoparvovirus Species 0.000 description 2
• 102100024692 Double-stranded RNA-specific editase B2 Human genes 0.000 description 2
• 102000001039 Dystrophin Human genes 0.000 description 2
• 108010069091 Dystrophin Proteins 0.000 description 2
• 241000283086 Equidae Species 0.000 description 2
• 241000282326 Felis catus Species 0.000 description 2
• 102000013446 GTP Phosphohydrolases Human genes 0.000 description 2
• 108091006109 GTPases Proteins 0.000 description 2
• 102000006479 Heterogeneous-Nuclear Ribonucleoproteins Human genes 0.000 description 2
• 108010019372 Heterogeneous-Nuclear Ribonucleoproteins Proteins 0.000 description 2
• 241001272567 Hominoidea Species 0.000 description 2
• 101000964322 Homo sapiens C->U-editing enzyme APOBEC-2 Proteins 0.000 description 2
• 101000964378 Homo sapiens DNA dC->dU-editing enzyme APOBEC-3A Proteins 0.000 description 2
• 101000964385 Homo sapiens DNA dC->dU-editing enzyme APOBEC-3B Proteins 0.000 description 2
• 101000964383 Homo sapiens DNA dC->dU-editing enzyme APOBEC-3C Proteins 0.000 description 2
• 101000964382 Homo sapiens DNA dC->dU-editing enzyme APOBEC-3D Proteins 0.000 description 2
• 101000964377 Homo sapiens DNA dC->dU-editing enzyme APOBEC-3F Proteins 0.000 description 2
• 101000686486 Homo sapiens Double-stranded RNA-specific editase B2 Proteins 0.000 description 2
• 101100021877 Homo sapiens LRRK2 gene Proteins 0.000 description 2
• 101000800426 Homo sapiens Putative C->U-editing enzyme APOBEC-4 Proteins 0.000 description 2
• 101000605835 Homo sapiens Serine/threonine-protein kinase PINK1, mitochondrial Proteins 0.000 description 2
• 101000664887 Homo sapiens Superoxide dismutase [Cu-Zn] Proteins 0.000 description 2
• 208000015178 Hurler syndrome Diseases 0.000 description 2
• 241000282596 Hylobatidae Species 0.000 description 2
• 101150081013 LRRK2 gene Proteins 0.000 description 2
• 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 description 2
• 241000282553 Macaca Species 0.000 description 2
• 206010056886 Mucopolysaccharidosis I Diseases 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• 208000022873 Ocular disease Diseases 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 206010033128 Ovarian cancer Diseases 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 241000282579 Pan Species 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 108091093037 Peptide nucleic acid Proteins 0.000 description 2
• 241000282405 Pongo abelii Species 0.000 description 2
• 102100027378 Prothrombin Human genes 0.000 description 2
• 108010094028 Prothrombin Proteins 0.000 description 2
• 102100033091 Putative C->U-editing enzyme APOBEC-4 Human genes 0.000 description 2
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 208000007014 Retinitis pigmentosa Diseases 0.000 description 2
• 108091028664 Ribonucleotide Proteins 0.000 description 2
• 102100038376 Serine/threonine-protein kinase PINK1, mitochondrial Human genes 0.000 description 2
• 241000282887 Suidae Species 0.000 description 2
• 108091026828 U2 spliceosomal RNA Proteins 0.000 description 2
• 108091026831 U4 spliceosomal RNA Proteins 0.000 description 2
• 108091026837 U5 spliceosomal RNA Proteins 0.000 description 2
• 230000001594 aberrant effect Effects 0.000 description 2
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
• UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
• 125000000304 alkynyl group Chemical group 0.000 description 2
• 125000004429 atom Chemical group 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000008499 blood brain barrier function Effects 0.000 description 2
• 210000001218 blood-brain barrier Anatomy 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• 208000037516 chromosome inversion disease Diseases 0.000 description 2
• 238000004590 computer program Methods 0.000 description 2
• 125000000753 cycloalkyl group Chemical group 0.000 description 2
• 230000009615 deamination Effects 0.000 description 2
• 238000006481 deamination reaction Methods 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 238000010494 dissociation reaction Methods 0.000 description 2
• 230000005593 dissociations Effects 0.000 description 2
• 208000014720 distal hereditary motor neuropathy Diseases 0.000 description 2
• NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 210000003527 eukaryotic cell Anatomy 0.000 description 2
• 108020001507 fusion proteins Proteins 0.000 description 2
• 102000037865 fusion proteins Human genes 0.000 description 2
• 229940029575 guanosine Drugs 0.000 description 2
• 210000003494 hepatocyte Anatomy 0.000 description 2
• 125000001072 heteroaryl group Chemical group 0.000 description 2
• 102000045354 human SNCA Human genes 0.000 description 2
• 102000056070 human SOD1 Human genes 0.000 description 2
• 125000001183 hydrocarbyl group Chemical group 0.000 description 2
• 230000003301 hydrolyzing effect Effects 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 210000002865 immune cell Anatomy 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 238000004654 kelvin probe force microscopy Methods 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 210000004901 leucine-rich repeat Anatomy 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• 230000017156 mRNA modification Effects 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 238000004949 mass spectrometry Methods 0.000 description 2
• 210000000663 muscle cell Anatomy 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 210000004940 nucleus Anatomy 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical class NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 2
• 229910052698 phosphorus Inorganic materials 0.000 description 2
• 125000003367 polycyclic group Chemical group 0.000 description 2
• 229940039716 prothrombin Drugs 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
• 238000003908 quality control method Methods 0.000 description 2
• 150000003254 radicals Chemical class 0.000 description 2
• 230000001177 retroviral effect Effects 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 239000002336 ribonucleotide Substances 0.000 description 2
• 125000002652 ribonucleotide group Chemical group 0.000 description 2
• 102200092155 rs35870237 Human genes 0.000 description 2
• 239000011669 selenium Substances 0.000 description 2
• 210000002027 skeletal muscle Anatomy 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 208000011580 syndromic disease Diseases 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 238000010361 transduction Methods 0.000 description 2
• 230000026683 transduction Effects 0.000 description 2
• 230000001052 transient effect Effects 0.000 description 2
• 210000004291 uterus Anatomy 0.000 description 2
• AUTOLBMXDDTRRT-JGVFFNPUSA-N (4R,5S)-dethiobiotin Chemical compound C[C@@H]1NC(=O)N[C@@H]1CCCCCC(O)=O AUTOLBMXDDTRRT-JGVFFNPUSA-N 0.000 description 1
• YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
• 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
• BTEKKSCHXGLMIJ-UHFFFAOYSA-N 2-phosphonoethanethioic S-acid Chemical compound OP(O)(=O)CC(S)=O BTEKKSCHXGLMIJ-UHFFFAOYSA-N 0.000 description 1
• 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
• 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
• 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
• 108091027075 5S-rRNA precursor Proteins 0.000 description 1
• HWRFTOWHSBECMR-UHFFFAOYSA-N 6-n-[(4-aminophenyl)methyl]-2-n-[[3-(trifluoromethyl)phenyl]methyl]-7h-purine-2,6-diamine Chemical class C1=CC(N)=CC=C1CNC1=NC(NCC=2C=C(C=CC=2)C(F)(F)F)=NC2=C1NC=N2 HWRFTOWHSBECMR-UHFFFAOYSA-N 0.000 description 1
• 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
• 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
• 108091034151 7SK RNA Proteins 0.000 description 1
• 102000012758 APOBEC-1 Deaminase Human genes 0.000 description 1
• 208000035657 Abasia Diseases 0.000 description 1
• 241000202702 Adeno-associated virus - 3 Species 0.000 description 1
• 241000580270 Adeno-associated virus - 4 Species 0.000 description 1
• 241001164823 Adeno-associated virus - 7 Species 0.000 description 1
• 241000649046 Adeno-associated virus 11 Species 0.000 description 1
• 102000055025 Adenosine deaminases Human genes 0.000 description 1
• 206010001557 Albinism Diseases 0.000 description 1
• 239000004254 Ammonium phosphate Substances 0.000 description 1
• 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 1
• 102000008102 Ankyrins Human genes 0.000 description 1
• 108010049777 Ankyrins Proteins 0.000 description 1
• 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 description 1
• 108020005544 Antisense RNA Proteins 0.000 description 1
• 108091023037 Aptamer Proteins 0.000 description 1
• 108010014223 Armadillo Domain Proteins Proteins 0.000 description 1
• 102000016904 Armadillo Domain Proteins Human genes 0.000 description 1
• 102000036365 BRCA1 Human genes 0.000 description 1
• 108700020463 BRCA1 Proteins 0.000 description 1
• 101150072950 BRCA1 gene Proteins 0.000 description 1
• 201000006935 Becker muscular dystrophy Diseases 0.000 description 1
• 102100040397 C->U-editing enzyme APOBEC-1 Human genes 0.000 description 1
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
• 208000016718 Chromosome Inversion Diseases 0.000 description 1
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
• 208000000094 Chronic Pain Diseases 0.000 description 1
• 208000035374 Chronic visceral acid sphingomyelinase deficiency Diseases 0.000 description 1
• 108091028075 Circular RNA Proteins 0.000 description 1
• 206010010356 Congenital anomaly Diseases 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 102000005381 Cytidine Deaminase Human genes 0.000 description 1
• 108010031325 Cytidine deaminase Proteins 0.000 description 1
• 102100039221 Cytoplasmic polyadenylation element-binding protein 3 Human genes 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• 241000289632 Dasypodidae Species 0.000 description 1
• 206010012289 Dementia Diseases 0.000 description 1
• 201000007547 Dravet syndrome Diseases 0.000 description 1
• 208000010975 Dystrophic epidermolysis bullosa Diseases 0.000 description 1
• 102100031780 Endonuclease Human genes 0.000 description 1
• 108010042407 Endonucleases Proteins 0.000 description 1
• 102000004533 Endonucleases Human genes 0.000 description 1
• 108060002716 Exonuclease Proteins 0.000 description 1
• 208000024720 Fabry Disease Diseases 0.000 description 1
• 108091092512 GIR1 branching ribozyme Proteins 0.000 description 1
• 102000001267 GSK3 Human genes 0.000 description 1
• 108060006662 GSK3 Proteins 0.000 description 1
• 208000027472 Galactosemias Diseases 0.000 description 1
• 208000015872 Gaucher disease Diseases 0.000 description 1
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
• 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
• 206010053185 Glycogen storage disease type II Diseases 0.000 description 1
• 108091027874 Group I catalytic intron Proteins 0.000 description 1
• 108091029499 Group II intron Proteins 0.000 description 1
• XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
• 108090001102 Hammerhead ribozyme Proteins 0.000 description 1
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
• 208000031220 Hemophilia Diseases 0.000 description 1
• 208000009292 Hemophilia A Diseases 0.000 description 1
• 208000008051 Hereditary Nonpolyposis Colorectal Neoplasms Diseases 0.000 description 1
• 206010051922 Hereditary non-polyposis colorectal cancer syndrome Diseases 0.000 description 1
• 101000745755 Homo sapiens Cytoplasmic polyadenylation element-binding protein 3 Proteins 0.000 description 1
• 101000959794 Homo sapiens Interferon alpha-2 Proteins 0.000 description 1
• 101000986595 Homo sapiens Ornithine transcarbamylase, mitochondrial Proteins 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 208000029462 Immunodeficiency disease Diseases 0.000 description 1
• 208000035343 Infantile neurovisceral acid sphingomyelinase deficiency Diseases 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102100040018 Interferon alpha-2 Human genes 0.000 description 1
• 108091029795 Intergenic region Proteins 0.000 description 1
• 108010029660 Intrinsically Disordered Proteins Proteins 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• 108090000004 Leadzyme Proteins 0.000 description 1
• 201000003533 Leber congenital amaurosis Diseases 0.000 description 1
• 208000009625 Lesch-Nyhan syndrome Diseases 0.000 description 1
• 201000005027 Lynch syndrome Diseases 0.000 description 1
• 208000035719 Maculopathy Diseases 0.000 description 1
• 208000001826 Marfan syndrome Diseases 0.000 description 1
• 208000002678 Mucopolysaccharidoses Diseases 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101100443350 Mus musculus Dmd gene Proteins 0.000 description 1
• 208000021642 Muscular disease Diseases 0.000 description 1
• 208000036572 Myoclonic epilepsy Diseases 0.000 description 1
• 206010068871 Myotonic dystrophy Diseases 0.000 description 1
• 208000009905 Neurofibromatoses Diseases 0.000 description 1
• 201000000794 Niemann-Pick disease type A Diseases 0.000 description 1
• 201000000791 Niemann-Pick disease type B Diseases 0.000 description 1
• 208000010577 Niemann-Pick disease type C Diseases 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 208000000599 Ornithine Carbamoyltransferase Deficiency Disease Diseases 0.000 description 1
• 206010052450 Ornithine transcarbamoylase deficiency Diseases 0.000 description 1
• 208000035903 Ornithine transcarbamylase deficiency Diseases 0.000 description 1
• 102100028200 Ornithine transcarbamylase, mitochondrial Human genes 0.000 description 1
• 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
• 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
• 108090000279 Peptidyltransferases Proteins 0.000 description 1
• 206010034764 Peutz-Jeghers syndrome Diseases 0.000 description 1
• 201000011252 Phenylketonuria Diseases 0.000 description 1
• ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• MTVVRWVOXZSVBW-UHFFFAOYSA-M QSY21 succinimidyl ester Chemical compound [Cl-].C1CN(S(=O)(=O)C=2C(=CC=CC=2)C2=C3C=CC(C=C3OC3=CC(=CC=C32)N2CC3=CC=CC=C3C2)=[N+]2CC3=CC=CC=C3C2)CCC1C(=O)ON1C(=O)CCC1=O MTVVRWVOXZSVBW-UHFFFAOYSA-M 0.000 description 1
• GMRIOMQGYOXUCH-UHFFFAOYSA-N QSY35 succinimidyl ester Chemical compound C12=NON=C2C([N+](=O)[O-])=CC=C1NC(C=C1)=CC=C1CC(=O)ON1C(=O)CCC1=O GMRIOMQGYOXUCH-UHFFFAOYSA-N 0.000 description 1
• BDJDTKYGKHEMFF-UHFFFAOYSA-M QSY7 succinimidyl ester Chemical compound [Cl-].C=1C=C2C(C=3C(=CC=CC=3)S(=O)(=O)N3CCC(CC3)C(=O)ON3C(CCC3=O)=O)=C3C=C\C(=[N+](\C)C=4C=CC=CC=4)C=C3OC2=CC=1N(C)C1=CC=CC=C1 BDJDTKYGKHEMFF-UHFFFAOYSA-M 0.000 description 1
• PAOKYIAFAJVBKU-UHFFFAOYSA-N QSY9 succinimidyl ester Chemical compound [H+].[H+].[Cl-].C=1C=C2C(C=3C(=CC=CC=3)S(=O)(=O)N3CCC(CC3)C(=O)ON3C(CCC3=O)=O)=C3C=C\C(=[N+](\C)C=4C=CC(=CC=4)S([O-])(=O)=O)C=C3OC2=CC=1N(C)C1=CC=C(S([O-])(=O)=O)C=C1 PAOKYIAFAJVBKU-UHFFFAOYSA-N 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 238000003559 RNA-seq method Methods 0.000 description 1
• 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 208000021811 Sandhoff disease Diseases 0.000 description 1
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 206010073677 Severe myoclonic epilepsy of infancy Diseases 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 108020003224 Small Nucleolar RNA Proteins 0.000 description 1
• 102000042773 Small Nucleolar RNA Human genes 0.000 description 1
• 108091027544 Subgenomic mRNA Proteins 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 108091046869 Telomeric non-coding RNA Proteins 0.000 description 1
• WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 description 1
• 206010043391 Thalassaemia beta Diseases 0.000 description 1
• 208000002903 Thalassemia Diseases 0.000 description 1
• 208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 1
• 108091028113 Trans-activating crRNA Proteins 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 208000007824 Type A Niemann-Pick Disease Diseases 0.000 description 1
• 208000008291 Type B Niemann-Pick Disease Diseases 0.000 description 1
• 208000007930 Type C Niemann-Pick Disease Diseases 0.000 description 1
• 108010007780 U7 Small Nuclear Ribonucleoprotein Proteins 0.000 description 1
• 101150078545 U7 gene Proteins 0.000 description 1
• 229910052770 Uranium Inorganic materials 0.000 description 1
• 208000014769 Usher Syndromes Diseases 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 108010017070 Zinc Finger Nucleases Proteins 0.000 description 1
• YIJVOACVHQZMKI-JXOAFFINSA-N [[(2r,3s,4r,5r)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 YIJVOACVHQZMKI-JXOAFFINSA-N 0.000 description 1
• VEWJOCYCKIZKKV-GBNDHIKLSA-N [[(2r,3s,4r,5s)-5-(2,4-dioxo-1h-pyrimidin-5-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1C1=CNC(=O)NC1=O VEWJOCYCKIZKKV-GBNDHIKLSA-N 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 230000001919 adrenal effect Effects 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical group OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
• HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 108010064397 amyloid beta-protein (1-40) Proteins 0.000 description 1
• 108010064539 amyloid beta-protein (1-42) Proteins 0.000 description 1
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
• 238000004458 analytical method Methods 0.000 description 1
• 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
• 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
• 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• DMLAVOWQYNRWNQ-UHFFFAOYSA-N azobenzene Chemical compound C1=CC=CC=C1N=NC1=CC=CC=C1 DMLAVOWQYNRWNQ-UHFFFAOYSA-N 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• 108091007737 beta-secretases Proteins 0.000 description 1
• 125000002619 bicyclic group Chemical group 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 210000003855 cell nucleus Anatomy 0.000 description 1
• 230000006800 cellular catabolic process Effects 0.000 description 1
• 208000011142 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Diseases 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 230000001886 ciliary effect Effects 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 239000003184 complementary RNA Substances 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• IBOVDNBDQHYNJI-UHFFFAOYSA-N dabcyl SE dye Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(=O)ON2C(CCC2=O)=O)C=C1 IBOVDNBDQHYNJI-UHFFFAOYSA-N 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 239000005549 deoxyribonucleoside Substances 0.000 description 1
• 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 description 1
• 125000000532 dioxanyl group Chemical group 0.000 description 1
• 125000005879 dioxolanyl group Chemical group 0.000 description 1
• ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 210000001198 duodenum Anatomy 0.000 description 1
• 210000004696 endometrium Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 208000004298 epidermolysis bullosa dystrophica Diseases 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 102000013165 exonuclease Human genes 0.000 description 1
• 210000001808 exosome Anatomy 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 210000001723 extracellular space Anatomy 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 125000001153 fluoro group Chemical group F* 0.000 description 1
• 125000002541 furyl group Chemical group 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 108091007739 gamma-secretases Proteins 0.000 description 1
• 102000038383 gamma-secretases Human genes 0.000 description 1
• 102000054766 genetic haplotypes Human genes 0.000 description 1
• 101150117187 glmS gene Proteins 0.000 description 1
• 238000002873 global sequence alignment Methods 0.000 description 1
• 102000018146 globin Human genes 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 201000004502 glycogen storage disease II Diseases 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 238000011194 good manufacturing practice Methods 0.000 description 1
• 108090001052 hairpin ribozyme Proteins 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 238000002744 homologous recombination Methods 0.000 description 1
• 230000006801 homologous recombination Effects 0.000 description 1
• 102000043770 human ADAR Human genes 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 125000002883 imidazolyl group Chemical group 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 230000007813 immunodeficiency Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
• 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
• 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
• 125000001041 indolyl group Chemical group 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 230000009878 intermolecular interaction Effects 0.000 description 1
• 230000007326 intracellular aggregation Effects 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 230000001057 ionotropic effect Effects 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 210000004558 lewy body Anatomy 0.000 description 1
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 208000002780 macular degeneration Diseases 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 208000030159 metabolic disease Diseases 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 210000000274 microglia Anatomy 0.000 description 1
• 230000007576 microinfarct Effects 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 230000009456 molecular mechanism Effects 0.000 description 1
• 125000002950 monocyclic group Chemical group 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• 125000002757 morpholinyl group Chemical group 0.000 description 1
• 206010028093 mucopolysaccharidosis Diseases 0.000 description 1
• 201000002273 mucopolysaccharidosis II Diseases 0.000 description 1
• 208000022018 mucopolysaccharidosis type 2 Diseases 0.000 description 1
• 108091005763 multidomain proteins Proteins 0.000 description 1
• 210000003098 myoblast Anatomy 0.000 description 1
• 210000000107 myocyte Anatomy 0.000 description 1
• 230000003274 myotonic effect Effects 0.000 description 1
• NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 210000004897 n-terminal region Anatomy 0.000 description 1
• 239000002539 nanocarrier Substances 0.000 description 1
• 239000002106 nanomesh Substances 0.000 description 1
• 125000001624 naphthyl group Chemical group 0.000 description 1
• 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 230000001613 neoplastic effect Effects 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 208000004296 neuralgia Diseases 0.000 description 1
• 201000004931 neurofibromatosis Diseases 0.000 description 1
• 208000021722 neuropathic pain Diseases 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 201000011278 ornithine carbamoyltransferase deficiency Diseases 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 125000002971 oxazolyl group Chemical group 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
• 239000002953 phosphate buffered saline Substances 0.000 description 1
• UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 210000000608 photoreceptor cell Anatomy 0.000 description 1
• 125000004193 piperazinyl group Chemical group 0.000 description 1
• 125000003386 piperidinyl group Chemical group 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 239000013600 plasmid vector Substances 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 208000015768 polyposis Diseases 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
• 208000002815 pulmonary hypertension Diseases 0.000 description 1
• 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
• 125000003373 pyrazinyl group Chemical group 0.000 description 1
• 125000002098 pyridazinyl group Chemical group 0.000 description 1
• 125000004076 pyridyl group Chemical group 0.000 description 1
• 125000000714 pyrimidinyl group Chemical group 0.000 description 1
• 125000004929 pyrrolidonyl group Chemical group N1(C(CCC1)=O)* 0.000 description 1
• 125000001422 pyrrolinyl group Chemical group 0.000 description 1
• 125000000168 pyrrolyl group Chemical group 0.000 description 1
• 125000005493 quinolyl group Chemical group 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 239000013074 reference sample Substances 0.000 description 1
• 230000037425 regulation of transcription Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000009711 regulatory function Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 210000003583 retinal pigment epithelium Anatomy 0.000 description 1
• 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
• 102200036624 rs104893875 Human genes 0.000 description 1
• 102200036626 rs104893877 Human genes 0.000 description 1
• 102200092237 rs10878307 Human genes 0.000 description 1
• 102200092229 rs111341148 Human genes 0.000 description 1
• 102200092158 rs111691891 Human genes 0.000 description 1
• 102220010583 rs111910483 Human genes 0.000 description 1
• 102220010533 rs113065049 Human genes 0.000 description 1
• 102220010573 rs113431708 Human genes 0.000 description 1
• 102200092153 rs113511708 Human genes 0.000 description 1
• 102220010563 rs113589830 Human genes 0.000 description 1
• 102200092166 rs11564148 Human genes 0.000 description 1
• 102200058742 rs121909568 Human genes 0.000 description 1
• 102200013794 rs121918339 Human genes 0.000 description 1
• 102200092162 rs145364431 Human genes 0.000 description 1
• 102200092169 rs145364431 Human genes 0.000 description 1
• 102200092228 rs17466213 Human genes 0.000 description 1
• 102200092151 rs201271001 Human genes 0.000 description 1
• 102220010535 rs202009639 Human genes 0.000 description 1
• 102200092236 rs281865043 Human genes 0.000 description 1
• 102200092233 rs281865044 Human genes 0.000 description 1
• 102200092234 rs281865045 Human genes 0.000 description 1
• 102220010555 rs281865046 Human genes 0.000 description 1
• 102220010568 rs281865048 Human genes 0.000 description 1
• 102220010572 rs281865050 Human genes 0.000 description 1
• 102220010576 rs281865051 Human genes 0.000 description 1
• 102200092164 rs281865053 Human genes 0.000 description 1
• 102220010589 rs281865055 Human genes 0.000 description 1
• 102200092304 rs281865057 Human genes 0.000 description 1
• 102200092223 rs33939927 Human genes 0.000 description 1
• 102200092172 rs33949390 Human genes 0.000 description 1
• 102200092218 rs33958906 Human genes 0.000 description 1
• 102200092156 rs33995883 Human genes 0.000 description 1
• 102200092159 rs34015634 Human genes 0.000 description 1
• 102200092238 rs34410987 Human genes 0.000 description 1
• 102200092154 rs34778348 Human genes 0.000 description 1
• 102200092216 rs34995376 Human genes 0.000 description 1
• 102200092239 rs35173587 Human genes 0.000 description 1
• 102200092170 rs35303786 Human genes 0.000 description 1
• 102200092217 rs35507033 Human genes 0.000 description 1
• 102200092163 rs35602796 Human genes 0.000 description 1
• 102220010596 rs35658131 Human genes 0.000 description 1
• 102200015429 rs36084898 Human genes 0.000 description 1
• 102200092303 rs3761863 Human genes 0.000 description 1
• 102200092173 rs56108242 Human genes 0.000 description 1
• 102200106842 rs573916965 Human genes 0.000 description 1
• 102220010546 rs58559150 Human genes 0.000 description 1
• 102200031910 rs587777453 Human genes 0.000 description 1
• 102200092232 rs60185966 Human genes 0.000 description 1
• 102200004723 rs60440396 Human genes 0.000 description 1
• 102200092221 rs7133914 Human genes 0.000 description 1
• 102220010557 rs72546324 Human genes 0.000 description 1
• 102220010562 rs72546327 Human genes 0.000 description 1
• 102220010536 rs72546335 Human genes 0.000 description 1
• 102220010544 rs72546337 Human genes 0.000 description 1
• 102220010561 rs72546338 Human genes 0.000 description 1
• 102200092175 rs7308720 Human genes 0.000 description 1
• 102220010569 rs74681492 Human genes 0.000 description 1
• 102220010554 rs74985840 Human genes 0.000 description 1
• 102200092230 rs76535406 Human genes 0.000 description 1
• 102200092161 rs77428810 Human genes 0.000 description 1
• 102220010590 rs78029637 Human genes 0.000 description 1
• 102220010552 rs78365431 Human genes 0.000 description 1
• 102200092302 rs78964014 Human genes 0.000 description 1
• 102220010599 rs79546190 Human genes 0.000 description 1
• 235000002020 sage Nutrition 0.000 description 1
• 210000003079 salivary gland Anatomy 0.000 description 1
• 229930195734 saturated hydrocarbon Natural products 0.000 description 1
• 238000005204 segregation Methods 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• JRPHGDYSKGJTKZ-UHFFFAOYSA-N selenophosphoric acid Chemical class OP(O)([SeH])=O JRPHGDYSKGJTKZ-UHFFFAOYSA-N 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 208000002491 severe combined immunodeficiency Diseases 0.000 description 1
• 208000007056 sickle cell anemia Diseases 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 159000000000 sodium salts Chemical class 0.000 description 1
• 239000000243 solution Substances 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000037436 splice-site mutation Effects 0.000 description 1
• 210000001324 spliceosome Anatomy 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 230000004960 subcellular localization Effects 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 108091035539 telomere Proteins 0.000 description 1
• 102000055501 telomere Human genes 0.000 description 1
• 210000003411 telomere Anatomy 0.000 description 1
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
• 125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
• 125000005308 thiazepinyl group Chemical group S1N=C(C=CC=C1)* 0.000 description 1
• 125000000335 thiazolyl group Chemical group 0.000 description 1
• YAHHPOUXPBUKTL-DXKBKMAZSA-N thymidine dimer Chemical compound CC12C(C3N([C@H]4C[C@H](O)[C@@H](CO)O4)C(=O)NC(=O)C13C)N([C@H]1C[C@H](O)[C@@H](CO)O1)C(=O)NC2=O YAHHPOUXPBUKTL-DXKBKMAZSA-N 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 239000011573 trace mineral Substances 0.000 description 1
• 235000013619 trace mineral Nutrition 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 238000003146 transient transfection Methods 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 125000001425 triazolyl group Chemical group 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
• 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 230000010415 tropism Effects 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 210000003932 urinary bladder Anatomy 0.000 description 1
• 108090000883 varkud satellite ribozyme Proteins 0.000 description 1
• 230000006496 vascular abnormality Effects 0.000 description 1
• 208000009935 visceral pain Diseases 0.000 description 1